The rise of copyright’s blockbuster initially drove a boom for pharma, but recent developments present a uncertain scenario for shareholders. Off-patent versions are eating into revenue, and persistent litigation add https://nevembsa960196.blogitright.com/41522336/viagra-and-the-pharmaceutical-industry-a-risky-investment